Agata Bielawska-Drózd

Agata Bielawska-Drózd

Auto-generated profile, based on publicly available information

Agata Bielawska-Drózd

Biological Threats Identification and Countermeasure Centre, Military Institute of Hygiene and Epidemiology, Warsaw, Poland

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2018 in Polish Journal of Microbiology
Verified
Journal Article
Open access
PDF file
PGPatrycja Głowacka
Patrycja Głowacka
DŻDorota Żakowska
Dorota Żakowska
Katarzyna NaylorKatarzyna Naylor
Katarzyna Naylor
MNMarcin Niemcewicz
Marcin Niemcewicz
ABAgata Bielawska-Drózd
Agata Bielawska-Drózd
Brucellae are Gram-negative, small rods infecting mammals and capable of causing disease called brucellosis. The infection results in abortion and sterility in domestic animals (sheeps, pigs, rams etc). Especially dangerous for humans are: Brucella melitensis, Brucella suis, Brucella abortus , and Brucella canis that trigger unspecific symptoms (flu-like manifestation). Brucella rods are introduced via host cells, by inhalation, skin abrasions, ingestion or mucosal membranes. The most important feature of Brucella is the ability to survive and multiply within both phagocytic and non-phagocytic cells. Brucella does not produce classical virulence factors: exotoxin, cytolisins, exoenzymes, plasmids, fimbria, and drug resistant forms. Major virulence factors are: lipopolysaccharide (LPS), T4SS secretion system and BvrR/BvrS system, which allow interaction with host cell surface, formation of an early, late BCV ( Brucella Containing Vacuole) and interaction with endoplasmic reticulum (ER) when the bacteria multiply. The treatment of brucellosis is based on two-drug therapy, the most common combinations of antibiotics are: doxycycline with rifampicin or fluoroquinolones with rifampicin. Currently, also other methods are used to disrupt Brucella intracellular replication (tauroursodeoxycholic acid or ginseng saponin fraction A).

10 June 2014 in Annals of Agricultural and Environmental Medicine
Verified
Journal Article
Open access
TMTomasz Mirski
Tomasz Mirski
MBMichał Bartoszcze
Michał Bartoszcze
ABAgata Bielawska-Drózd
Agata Bielawska-Drózd
PCPiotr Cieślik
Piotr Cieślik
AMAleksander J. Michalski
Aleksander J. Michalski
KCKrzysztof Chomiczewski
Krzysztof Chomiczewski
Modern threats of bioterrorism force the need to develop methods for rapid and accurate identification of dangerous biological agents. Currently, there are many types of methods used in this field of studies that are based on immunological or genetic techniques, or constitute a combination of both methods (immuno-genetic). There are also methods that have been developed on the basis of physical and chemical properties of the analytes. Each group of these analytical assays can be further divided into conventional methods (e.g. simple antigen-antibody reactions, classical PCR, real-time PCR), and modern technologies (e.g. microarray technology, aptamers, phosphors, etc.). Nanodiagnostics constitute another group of methods that utilize the objects at a nanoscale (below 100 nm). There are also integrated and automated diagnostic systems, which combine different methods and allow simultaneous sampling, extraction of genetic material and detection and identification of the analyte using genetic, as well as immunological techniques.

1 January 2018 in Polish Journal of Microbiology
Verified
Journal Article
Open access
PDF file
ABAgata Bielawska-Drózd
Agata Bielawska-Drózd
PCPiotr Cieślik
Piotr Cieślik
DŻDorota Żakowska
Dorota Żakowska
PGPatrycja Głowacka
Patrycja Głowacka
BWBożena Wlizło-Skowronek
Bożena Wlizło-Skowronek
AZArkadiusz Zdun
Arkadiusz Zdun
This work presents results of the research on the occurrence of Coxiella burnetii and Francisella tularensis in the tissues of wild-living animals and ticks collected from Drawsko County, West Pomeranian Voivodeship. The real-time PCR testing for the pathogens comprised 928 samples of animal internal organs and 1551 ticks. The presence of C. burnetii was detected in 3% of wild-living animals and in 0.45–3.45% (dependent on collection areas) of ticks. The genetic sequences of F. tularensis were present in 0.49 % of ticks (only in one location – Drawa) and were not detected in animal tissues. The results indicate respectively low proportion of animals and ticks infected with C. burnetii and F. tularensis .

17 February 2022 in Annals of Agricultural and Environmental Medicine
Verified
Journal Article
Open access
AMAleksander Michalski
Aleksander Michalski
JKJózef Knap
Józef Knap
ABAgata Bielawska-Drózd
Agata Bielawska-Drózd
MBMichał Bartoszcze
Michał Bartoszcze
Introduction and objective: The aim of the study was to analyze available literature on the development of biological warfare and combating the SARS CoV-2 pandemic. Against the background of contemporary threats from biological factors, the strengths and weaknesses of response in the event of a...

1 December 2014 in Veterinary Microbiology
Verified
Journal Article
Open access
ABAgata Bielawska-Drózd
Agata Bielawska-Drózd
PCPiotr Cieślik
Piotr Cieślik
TMTomasz Mirski
Tomasz Mirski
JGJerzy Gaweł
Jerzy Gaweł
AMAleksander Michalski
Aleksander Michalski
JKJanusz Kocik
Janusz Kocik
Coxiella burnetii is the etiologic agent of Q fever. It may occur as two different morphological forms, a large cell variant (LCV) and a small cell variant (SCV). The SCV is characterized by unique resistance to physical and chemical factors and may survive in the environment for many months. The objective of this study was to examine environmental samples for the presence of C. burnetii using real-time PCR in areas where Q fever was previously reported and in randomly selected animal farms where Q fever was not reported. The samples were collected in the following provinces in Poland: Lublin, Subcarpathian and Masovian. Monitoring was performed with real-time PCR and serological methods. Of the 727 environmental samples, 33 (4.54%) contained the multi-copy insertion sequence IS1111, which is specific for C. burnetii. Subsequently, the presence of C. burnetii antibodies was determined using serological tests in selected herds in which positive genetic results were obtained. Serological analyses of 169 serum samples using CFT and ELISA were performed on Polish black-and-white Holstein-Friesian cows and one cow imported from Denmark. Using the CFT method, 11 samples were positive for phase I antibodies and six were positive for phase II antibodies. Moreover, in two cases, the presence of antibodies specific for both phase I and phase II antigens of C. burnetii was detected. However, of the 169 examined serum samples, 20 were positive by ELISA test, of which six were also positive by CFT. Additionally, multi spacer typing (MST) of isolated C. burnetii strains was performed. The MST results identified two new genotypes in Poland, ST3 and ST6. The results indicate that continued research regarding spread of this pathogen within a country is necessary.

11 May 2015 in Annals of Agricultural and Environmental Medicine
Verified
Journal Article
Open access
DŻDorota Żakowska
Dorota Żakowska
MBMichał Bartoszcze
Michał Bartoszcze
MNMarcin Niemcewicz
Marcin Niemcewicz
ABAgata Bielawska-Drózd
Agata Bielawska-Drózd
JKJózef Knap
Józef Knap
JKJanusz Kocik
Janusz Kocik
Bacillus anthracis is one of biological agents which may be used in bioterrorism attacks. The aim of this study a review of the new treatment possibilities of anthrax, with particular emphasis on the treatment of pulmonary anthrax. Abbreviated description of the state of knowledge. Pulmonary anthrax, as the most dangerous clinical form of the disease, is also extremely difficult to treat. Recently, considerable progress in finding new drugs and suitable therapy for anthrax has been achieved, for example, new antibiotics worth to mentioning, levofloxacin, daptomycin, gatifloxacin and dalbavancin. However, alternative therapeutic options should also be considered, among them the antimicrobial peptides, characterized by lack of inducible mechanisms of pathogen resistance. Very promising research considers bacteriophages lytic enzymes against selected bacteria species, including antibiotic-resistant strains. Interesting results were obtained using monoclonal antibodies: raxibacumab, cAb29 or cocktails of antibodies. The application of CpG oligodeoxynucleotides to boost the immune response elicited by Anthrax Vaccine Adsorbed and CMG2 protein complexes, also produced satisfying therapy results. Furthermore, the IFN-α and IFN-β, PA-dominant negative mutant, human inter-alpha inhibitor proteins and LF inhibitors in combination with ciprofloxacin, also showed very promising results. Recently, progress has been achieved in inhalation anthrax treatment. The most promising new possibilities include: new antibiotics, peptides and bacteriophages enzymes, monoclonal antibodies, antigen PA mutants, and inter alpha inhibitors applications. In the case of the possibility of bioterrorist attacks, the examination of inhalation anthrax treatment should be intensively continued.